IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.409
EU - Europa 659
AS - Asia 74
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
SA - Sud America 6
AF - Africa 2
Totale 3.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.312
IT - Italia 297
SE - Svezia 136
GB - Regno Unito 111
CA - Canada 96
DE - Germania 51
CN - Cina 24
IN - India 16
FR - Francia 14
RU - Federazione Russa 8
IE - Irlanda 7
RO - Romania 7
AU - Australia 6
ES - Italia 5
EU - Europa 5
FI - Finlandia 5
JP - Giappone 5
IR - Iran 4
TR - Turchia 4
UA - Ucraina 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CL - Cile 3
IL - Israele 3
PT - Portogallo 3
SG - Singapore 3
AT - Austria 2
CO - Colombia 2
HK - Hong Kong 2
ID - Indonesia 2
PK - Pakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BR - Brasile 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
MX - Messico 1
MY - Malesia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 3.164
Salva come PNG Salva come JPEG
Città #
Chandler 579
Lawrence 227
Princeton 227
Wilmington 143
London 103
Chicago 97
Ottawa 91
Des Moines 72
Catanzaro 71
Ashburn 51
Redwood City 19
Norwalk 18
Hanover 16
Redmond 15
Troina 15
Seattle 13
Naples 11
Florence 9
Pune 9
Rome 9
Augusta 7
Boardman 7
Dublin 7
Falls Church 7
Milan 7
Rogliano 7
Assago 6
Ferrara 6
Mountain View 6
Salerno 6
Helsinki 5
Paris 5
Shenyang 5
Turin 5
Ann Arbor 4
Bologna 4
Cherasco 4
Crotone 4
Horia 4
Padova 4
Palermo 4
Providence 4
San Mateo 4
Aiello Calabro 3
Ankara 3
Brookline 3
Houston 3
Jinan 3
Kemerovo 3
Rende 3
Shanghai 3
Taranto 3
Wake Forest 3
Anzio 2
Aversa 2
Bogotá 2
Campobasso 2
Clearwater 2
Cosenza 2
Cupertino 2
Delhi 2
Fara in Sabina 2
Foggia 2
Girona 2
Guangzhou 2
Lamezia Terme 2
Lecco 2
Legnano 2
Madrid 2
Marseille 2
Nagold 2
Nashville 2
New York 2
Novokuznetsk 2
Pozzuoli 2
Rapallo 2
Singapore 2
Taipei 2
West Jordan 2
Acerra 1
Amadora 1
Andover 1
Augsburg 1
Baabda 1
Bellinzona 1
Binasco 1
Bolton 1
Braunschweig 1
Brierley Hill 1
Brisbane 1
Budapest 1
Buffalo 1
Cachan 1
Cairo 1
Calgary 1
Chengdu 1
Dearborn 1
Dhaka 1
Dorchester 1
Downers Grove 1
Totale 2.020
Salva come PNG Salva come JPEG
Nome #
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 45
Application of proteomics and peptidomics to COPD 39
Asthma and COPD proteomics: Current approaches and future directions 38
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 36
High-flow nasal oxygen therapy in intensive care and anaesthesia 35
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 32
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 31
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 29
A case of alveolar proteinosis associated with pulmonary nocardiosis 29
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 29
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 29
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 29
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 28
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 28
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 28
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 27
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 27
Enfisema polmonare 27
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 26
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 26
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 25
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 25
Bronchial asthma induced by an antithyroid drug 24
Airways smooth muscle response to biological stimuli 24
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 24
Adverse drug reactions in hospitalized patients following antibiotics administration 24
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 24
Adverse drug reactions in hospitalized patients following NSAIDs administration 24
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 24
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 23
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 23
VIP: a new promising marker for AECOPD or a fashionable marker soon forgotten? 23
I beta2-adrenergici 23
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 23
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 23
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 23
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 22
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 22
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma 22
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 22
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 22
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 22
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 22
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 22
The severe asthma network in Italy: findings and perspectives 21
Dupilumab: a novel treatment for asthma 21
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 21
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 21
Agonisti beta2-adrenergici 21
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 21
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 20
Alpha-interferon and its effects on signal transduction pathways 20
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 20
Exhaled nitric oxide during humming: potential clinical tool in sinonasal disease? 20
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 20
Role of biologics in severe eosinophilic asthma - focus on reslizumab 20
Adverse drug reactions in hospitalized patients following bronchodilators administration 20
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 20
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 20
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 20
Nitric oxide in upper airways inflammatory diseases 19
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 19
Respiratory infections and asthma 19
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 19
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 19
Oxidative Stress and Respiratory Disease 19
Omalizumab riduce la frequenza delle riacutizzazioni, l’assunzione orale di corticosteroidi e l’eosinofilia ematica in pazienti atopici con asma cronico severo 19
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 19
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 19
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 19
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 19
Effects of specific immunotherapy in bronchial hyperresponsiveness 18
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 18
Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics 18
III. Biologia molecolare della recezione e della trasduzione dei segnali 18
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 18
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 18
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 18
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 17
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review 17
I CORTICOSTEROIDI 17
Basi biomolecolari delle pneumopatie interstiziali: Azione degli steroidi sul rilascio delle citochine 17
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 17
Anticolinergici 17
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 17
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 17
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 17
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 17
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 17
New perspectives in asthma treatment 16
Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol/glycopyrronium 16
Targeted therapy in severe asthma today: focus on immunoglobulin E 16
Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients 16
Communication to the Editor 16
Effetti dei cortisonici sull’attivazione delle “mitogen-activated protein kinases” 16
Methimazole-Induced Asthma. Letter to Editor 16
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 16
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 16
Regulation of beta2-adrenergic receptors and the implications for bronchial asthma: an update 15
Antimuscarinici 15
Totale 2.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 8 27 23 4 17 9 4 19 105
2020/2021242 27 2 7 33 24 13 7 6 86 25 6 6
2021/2022596 4 4 32 112 45 18 31 140 53 57 90 10
2022/20231.694 465 66 67 127 184 171 16 115 274 78 109 22
2023/2024616 141 90 59 37 36 170 14 24 8 27 10 0
Totale 3.364